Sound more like science fiction than actual science? Then, brace yourself because there are, at least, 15 breast cancer ...

The recommendation addresses a long-standing treatment gap for patients facing bladder removal after standard therapy fails.

When cells can’t destroy damaged proteins, a hidden backup system led by NRF1 steps in to prevent toxic buildup.

A newly engineered antibody can penetrate kidney cysts and interrupt the growth signals that drive polycystic kidney disease.

Study published in Nature Cell Biology is fundamental in understanding the ways in which cancer cells can develop drug ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Now, it’s open to almost everyone who can afford it. Companies will offer to test for hundreds of genes to help people make ...

A strange, contagious cancer is threatening Tasmanian devils, but researchers’ fight is fueling breakthroughs in science, ...

One of the most prominent actors in the world is taking a moment to raise awareness about a very serious issue. The ...

MEDSIR, a leading international company in oncology research, has announced the results of the PHERGuide study during the 2025 San Antonio Breast Cancer Symposium (SABCS). This research, presented as ...

Precision measurement technology to assure the quality of products on assembly lines across the U.S. -- Fostering an excellence in surgical care from the first precision clinical microscopes and ...

A study published in the Journal of Clinical Oncology confirms that one of the first Food and Drug Administration-approved CAR-T cell therapies offers long-term survival and potential cures for adult ...